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Transcriptional Regulation and
Macrophage Diﬀerentiation
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1University of Edinburgh, The Roslin Institute and Royal (Dick) School of Veterinary Studies,
Midlothian EH25 9RG, United Kingdom; 2University Hospital Regensburg,
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ABSTRACT Monocytes and macrophages are professional
phagocytes that occupy speciﬁc niches in every tissue of
the body. Their survival, proliferation, and diﬀerentiation are
controlled by signals from the macrophage colony-stimulating
factor receptor (CSF-1R) and its two ligands, CSF-1 and
interleukin-34. In this review, we address the developmental
and transcriptional relationships between hematopoietic
progenitor cells, blood monocytes, and tissue macrophages as
well as the distinctions from dendritic cells. A huge repertoire
of receptors allows monocytes, tissue-resident macrophages,
or pathology-associated macrophages to adapt to speciﬁc
microenvironments. These processes create a broad spectrum
of macrophages with diﬀerent functions and individual eﬀector
capacities. The production of large transcriptomic data sets in
mouse, human, and other species provides new insights into
the mechanisms that underlie macrophage functional plasticity.
THE CELLS OF THE MONONUCLEAR
PHAGOCYTE SYSTEM
The mononuclear phagocyte system (MPS) was origi-
nally deﬁned by van Furth and Cohn (1) as a family of
cells of the innate immune system derived from hema-
topoietic progenitor cells under the inﬂuence of speciﬁc
growth factors (2, 3). Differentiated cells of the MPS,
monocytes and macrophages, are effectors of innate im-
munity, engulﬁng and killing pathogens. They are also
needed for tissue repair and resolution of inﬂamma-
tion and for the generation of an appropriate acquired
immune response. Their biology and differentiation
have been reviewed by a number of authors (2, 4–8). The
original deﬁnition of the MPS considered an essentially
linear sequence from pluripotent progenitors, through
committed myeloid progenitors shared with granulo-
cytes, to promonocytes and blood monocytes, and thence
to tissue macrophages (2, 4–8). Resident macrophages
differ in function between tissues, and within tissues
they occupy a speciﬁc niche (9). In some locations, for
example, associated with epithelia, they clearly have in-
dividual identiﬁable territories that form a regular pat-
tern (2, 3).
THE BIOLOGY OF BLOOD
MONOCYTE SUBSETS
Monocytes in peripheral blood have been subdivided
into subsets based on certain surface markers (4, 9–13).
The seminal study in the area of monocyte subset func-
tion (14) segregated mouse peripheral blood monocytes
based on their expression of chemokine receptors and
behavior on adoptive transfer; those expressing CCR2
(and the marker Ly6C) were recruited to inﬂammatory
sites, whereas those expressing CX3CR1 were selec-
tively recruited to noninﬂammatory sites. Subsequent
mouse studies have indicated that Ly6Chi monocytes
replenish the large resident macrophage population of
the gastrointestinal tract (15–18) and patrol the extra-
vascular space in many other organs (19). The more
mature Ly6Clo populations, which have a much longer
half-life in the circulation, may perform a patrolling
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function in the circulation and sense nucleic acids and
viruses (16, 20, 21). The subsets have also been referred
to as “classical” (Ly6Chi in mice or CD14hi in humans)
and “nonclassical” (Ly6Clo in mice or CD16hi in hu-
mans) under a proposed unifying nomenclature (11,
13). Given the lack of correlation between markers, and
species differences, it is likely that these populations
could be further subdivided into different and/or smaller
subsets using additional markers. Rather than give the
subsets names, it may be better to refer speciﬁcally to the
markers used. Expression array proﬁling of human and
mouse monocyte subsets deﬁned by the markers de-
scribed above (Ly6C and CD14/16) supported the idea
that these subsets were functionally equivalent across
species, although there were many species-speciﬁc ex-
pression differences (22). One major difference between
mice and humans is the relative abundance of the sub-
sets. In mice, the major populations are equally abun-
dant, whereas in humans, the CD16hi subset is a minor
subpopulation that also varies widely with disease
states. CD16 as a marker is also difﬁcult to interpret
since there is extensive copy number variation in the
gene encoding this marker, FCG3RB, underlying in-
ﬂammatory disease susceptibility in humans (23). In hu-
mans, an “intermediate” population (CD14int, CD16int)
has been identiﬁed and attributed specialized functions
(10–13). As discussed further below, the deﬁnition of
the intermediate population depends somewhat on the
position of gates on the ﬂuorescence-activated cell sort-
er, and the use of other markers such as SLAN and TIE2
may produce distinct subsets (10, 12). Bovine monocytes
have also been subdivided based on CD14 and CD16 as
markers, with CD172a (SIRPA) and CD163 providing
additional markers that varied between subpopulations
(24). Pig peripheral blood monocytes, which were more
human-like than were mouse macrophages in their over-
all gene expression proﬁles, could also be subdivided
into roughly equal subsets, depending on reciprocal ex-
pression of CD14 and CD163, but appeared to lack a
genuine “nonclassical” population (25). In rats, a sepa-
rate marker, CD43, separates monocytes into two pop-
ulations (26). As in the mouse, these populations differ
in their expression of chemokine receptors CCR2 and
CX3CR1 (26). CD43 expression also differs between
the mouse monocyte subpopulations (27). Adoptive
transfer and lineage trace studies in the mouse and rat
conﬁrmed that the mature (Ly6loCD43hi) cells derive
from the Ly6ChiCD43lo cells (26, 28, 29). The monocyte
subpopulations are therefore likely to be the extremes
of a differentiation series, in which the time spent in
transition is relatively short.
THE DEVELOPMENT OF THE MPS
During embryonic development in the mouse, macro-
phages are ﬁrst identiﬁable as a distinct cell type in the
yolk sac, and from that location they migrate and in-
ﬁltrate all of the tissues of the body. In mice, the ﬁrst
appearance occurs in Reichert’s membrane (30). The
yolk sac-derived macrophages are apparently generated
as mature macrophages, without an obvious monocyte-
like intermediate, and are highly motile, actively phago-
cytic, and proliferative (31–33). In outbred mice, these
yolk sac-derived macrophages lacked detectable ex-
pression of the macrophage-speciﬁc transcription factor
PU.1, and the null mutation of the Spi1 gene encoding
PU.1 did not compromise their development (32, 33).
Subsequent studies demonstrated that the impact of the
Spi1 knockout mutation depends strongly on genetic
background; in some strains the knockout is midges-
tation lethal, whereas in others it is myelodeﬁcient at
birth (34). The initial view, based on studies in the chick,
was that yolk sac-derived macrophages are replaced
later in development by the products of deﬁnitive he-
matopoiesis (35). This view was strongly supported by
recent cellular transplantation studies in the chicken,
where yolk sac cells injected into early embryos pro-
duced macrophages that were lost by the time of hatch,
but bone marrow-derived cells produced long-term
chimerism (36). Unexpectedly, this chimerism was re-
stricted to the macrophage lineage, suggesting the exis-
tence of a macrophage-restricted progenitor cell in the
bone marrow that has self-renewal capacity. There is
also some evidence for such a progenitor in the mouse
(37–39).
In the mouse, an emerging consensus is that popula-
tions of tissue macrophages, notably the microglia of
the brain (40), the epidermal macrophages (Langerhans
cells) of the skin (41, 42), and alveolar macrophages of
the lung (43), are seeded from the yolk sac or fetal liver
during development, and thereafter are maintained by
self-renewal (reviewed in reference 38). However, this
consensus depends on assumptions about the validity of
the models used. Almost all of these studies use a single
inbred mouse strain, C57BL/6, because most knockouts
and conditional reporters have been made on this back-
ground. By contrast to the outbred mice, in the C57BL/6
line yolk sac macrophages were apparently dependent
on PU.1, which was expressed in the yolk sac, and were
independent of the expression of c-MYB, which is ex-
pressed in deﬁnitive hematopoietic stem cells (HSCs)
(44). The view that the yolk sac is a major source of
tissue macrophages in the adult has been extended to
the point where blood monocytes are no longer believed
2 ASMscience.org/MicrobiolSpectrum
Hume et al.
Downloaded from www.asmscience.org by
IP:  129.215.46.118
On: Mon, 20 Jun 2016 13:21:46
to make a signiﬁcant contribution to any tissue macro-
phage population (29, 44, 45) other than that of the
gastrointestinal tract (46). The vast majority of adult
tissue-resident macrophages in adult mouse liver, brain,
skin, and lung were proposed to originate from yolk sac
erythromyeloid progenitors, distinct from HSCs that
colonize the fetal liver, with minimal replacement from
HSC progeny (via blood monocytes) even by 1 year of
age (47, 48).
Other authors, using different experimental models,
have reached a different conclusion about the role of the
yolk sac and embryonic macrophages in adult macro-
phage populations. Epelman et al. (49) reported that
∼50%of macrophages in most organs, other than brain,
were labeled with a conditional reporter driven by the
Flt3 promoter, which is expressed in HSCs. Neither
Flt3mRNA nor the conditional reporter was detected in
the yolk sac, and they were relatively low even in fetal
liver. Sheng et al. (50), using a conditional reporter gene
based on the Kit locus, which is expressed only in HSCs,
also concluded that the large majority of tissue mac-
rophages derive from deﬁnitive progenitors. On the
basis of these data, one would conclude that deﬁnitive
marrow-derived macrophages gradually replace those of
embryonic origin. The most recent contribution to this
emerging ﬁeld made the interesting observation that the
yolk sac-derived macrophages could be ablated with
injection of antibody to macrophage colony-stimulating
factor receptor (CSF-1R) into the embryo, and they were
apparently replaced by distinct c-MYB-dependent fetal
liver-derived monocytes by the end of gestation (51).
These authors used inducible lineage trace markers to
support the view that the large majority of tissue mac-
rophages are derived from fetal liver-derived monocytes
that seed tissue in the embryo and then self-renew. They
reiterate the view that microglia are derived exclusively
from the yolk sac macrophage population. However,
in mice treated with anti-CSF-1R the microglia were
repopulated, presumably from the monocytic source, by
the time of birth. This ﬁnding may relate to much earlier
observations, using outbred mice, that monocytes en-
tered the brain, and especially the retina, and clearly
transdifferentiated into microglia, around the time of
birth (52, 53).
HOMEOSTASIS AND THE
MACROPHAGE NICHE
As noted above, the distribution of macrophages in
tissues is very regular; individual cells occupy a speciﬁc
niche and seldom overlap processes with each other.
Each of the models used to infer the origins and turnover
of tissue macrophages in mice makes the assumption
that the methods used do not disturb the steady state,
and this assumption may also not be valid. The pro-
liferation and differentiation of macrophages is con-
trolled by CSF-1R, which is activated by two ligands,
macrophage colony-stimulating factor (CSF-1) and in-
terleukin-34 (IL-34) (7, 54). Administration of CSF-1 to
mice promoted expansion of the monocyte pool and
increased monocyte inﬁltration into tissues and tissue-
resident macrophage proliferation (55–57). CSF-1 is
cleared from the circulation through receptor-mediated
endocytosis by the CSF-1 receptor, involving both the
macrophages of the liver and spleen (58) and blood
monocytes (29). Accordingly, blockade of the CSF-1R
with a monoclonal antibody causes a massive increase
in circulating CSF-1 (59). The central role of CSF-1 in
macrophage homeostasis is evident from the CSF-1-
deﬁcient osteopetrotic (Csf1op/op) mouse and toothless
rat (Csf1tl/tl), which have gross deﬁciencies of tissue mac-
rophages and many pleiotropic consequences of that
deﬁciency (60). Treatment with anti-CSF-1R antibody
also depletes most tissue macrophage populations in
adult mice, indicating that CSF-1 dependence is main-
tained throughout life. Anti-CSF-1R does not deplete
monocytes (59), nor does it impact on monocytopoiesis
(61), but it does prevent differentiation to form the
Ly6Clo population (29, 59).
Based on the available data, there is an intrinsic CSF-1/
CSF-1R feedback loop that controls monocyte numbers
and differentiation, monocyte recruitment, and tissue
macrophage numbers through the local and systemic
availability of CSF-1. When an individual macrophage
niche becomes vacant, CSF-1 is no longer consumed and
the local CSF-1 concentration rises to promote either
local proliferation or recruitment of blood monocytes.
Studies of development and turnover of mononuclear
phagocytes need to take account of this homeostatic
loop. Inducible Cre reporters, bone marrow transplan-
tation, parabiosis, and monocyte depletion/mutations are
all very likely to alter the homeostatic balance by altering
the availability of CSF-1 (17). For example, the estrogen
analog tamoxifen is commonly used in lineage trace
experiments. There is evidence that CSF-1 expression is
regulated by estrogen and is elevated in ovariectomized
mice and in pregnancy (62, 63). Furthermore, hemato-
poietic progenitor cells respond directly to estrogen,
which modulates their differentiation in the presence of
myeloid growth factors (64). When embryos are pulsed
with tamoxifen to induce recombinase activity, the same
treatment may induce or repress CSF-1 in the embryo or
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the mother and alter the relative contribution of yolk sac
phagocytes. Once a macrophage niche has been occupied
by a yolk sac-derived progenitor, it may be less available
to cells of deﬁnitive origin. Similarly, the lack of any im-
pact on tissue macrophage numbers when monocytes are
depleted (for example, in MYB or CCR2 knockout mice)
could be explained by the increased availability of cir-
culating CSF-1 (29), leading to the compensatory pro-
liferation of the tissue-resident macrophages.
TRANSCRIPTOMIC ANALYSIS OF THE
RELATIONSHIP BETWEEN MACROPHAGES
AND DENDRITIC CELLS
The functional deﬁnition of a macrophage is in the
name, “big eater,” coined by Elie Metchnikoff (65). One
might expect that the set of genes required to make up a
professional phagocyte would be coexpressed in macro-
phages, and this might also provide clues to the function
of genes for which there is poor annotation. The prin-
ciple of guilt by association has been conﬁrmed many
times in analysis of large data sets. Genes that are co-
expressed at the mRNA level commonly encode pro-
tein products that participate in the same pathway or
process (66–68). Since the pioneering efforts of Su et al.
(69) to generate the SymAtlas (now BioGPS; http://biogps
.org) from sets of microarray data from mouse and hu-
man tissues, there have been numerous gene expression
“atlases” across multiple tissues and within tissues across
cell types and developmental time. The network tool
BioLayout Express3D was developed to allow the visual-
ization of coexpression relationships in large data sets (70,
71) and was used to dissect the mouse BioGPS data set
(67) and subsequently in a meta-analysis of publicly avail-
able mouse (72) and human data (73) relating to hema-
topoietic differentiation and macrophage biology and in
a preliminary pig expression atlas (66). BioLayout anal-
ysis was used to identify a large set of coexpressed genes
that were most highly expressed in phagocytes and that
encoded proteins associated with lysosomes, including all
of the components of the vacuolar ATPase proton pump
and lysosomal hydrolases. This lysosomal/endocytosis
cluster of coexpressed genes included those encoding
transcription factors such as PU.1 and C/EBP (CCAAT/
enhancer-binding protein) that likely contribute to tran-
scriptional control in macrophage differentiation, and
indeed can drive differentiation to a phagocyte pheno-
type when expressed in ﬁbroblasts (74). The promoters of
these phagocyte-enriched genes, in common with those of
known human lysosomal proteins (75), contained purine-
rich motifs, binding sites for the macrophage transcrip-
tion factor PU.1, and the recognition motifs for basic
helix-loop-helix transcription factors of the microphthal-
mia transcription factor family: MITF, TFEB, TFEC, and
TFE3. All four MITF family members are expressed in
macrophages. TFEC is a macrophage-speciﬁc transcrip-
tion factor and itself a PU.1 target gene (76). MITF in-
teracts both physically and genetically with PU.1 (34) and
can transactivate the promoter of the ACP5 lysosomal
enzyme gene (34).
By contrast to the clear coexpression of phagocyte-
speciﬁc genes, the genes encoding surface antigen
markers, recognized by monoclonal antibodies, that
are commonly used to divide monocytes and macro-
phages into subpopulations, were not stringently co-
expressed with either phagocytic function or with each
other. The gene encoding the well-studied macrophage
marker EMR1 (F4/80), for example, was in a very small
coexpression cluster with the gene for a transcription
factor, MAFB, that was subsequently shown to regulate
its expression (77, 78). High expression of F4/80 was
proposed as a marker for tissue macrophages that derive
from yolk sac progenitors (44). The clear lack of corre-
lation between surface markers is important because
it means that we cannot predict the gene expression
or surface antigen proﬁle of individual cells based on the
presence of any marker. Each of the proteins we regard
as surface markers has a function and has its own in-
trinsic regulation.
One of the most prevalent uses of surface markers
is the separation of macrophages from dendritic cells
(DCs) and the segregation of both populations into
subpopulations. The activation of T lymphocytes re-
quires the presentation of the antigen on major histo-
compatibility complex (MHC) molecules on the surface
of an antigen-presenting cell (APC). For some groups,
the term “dendritic cell” has been merged with “antigen-
presenting cell.” The problem with this view is that
antigen presentation is a regulated pathway, and the
genes involved are not correlated with any other cellular
function. For some signiﬁcant time, the integrin CD11c
(ITGAX) was considered a DC marker in mice, even
though it was clearly expressed by many tissue macro-
phage populations (6, 79). In the cluster analysis of
mouse BioGPS data, CD11c was not coexpressed with
any other marker (67).
The original description of the classical DC by
Steinman and Cohn made the clear distinction that
“unlike macrophages, they do not appear to engage in
active endocytosis” (80). Analysis of large transcripto-
mic data sets reveals that the a priori deﬁnition of cells as
DCs currently groups together cells with very distinct
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transcriptional proﬁles (6, 17, 79, 81, 82). The Immu-
nological Genome Consortium (ImmGen) produced
transcriptomic proﬁles from a large number of different
myeloid cell populations isolated from multiple mouse
tissues based on cell surface marker expression, and
proposed distinct expression signatures unique to DCs
and macrophages (83, 84). Their analysis concluded
that MHC class II (MHC-II) and the transcriptional
regulator CIITA were part of a DC signature, which
was predictable given the selection of MHC-II-negative
macrophages for comparison. A separate analysis of the
entire data set failed to identify coexpressed genes that
correlated with the a priori deﬁnition of cells as mac-
rophages or DCs (85). Even within this large myeloid-
speciﬁc data set, there was no correlation between any
of the cell surface receptors, such as CD11b, CD11c,
F4/80, MHC-II, CD64, CSF-1R, and FLT3, that are
commonly used to classify subpopulations or cell types
of macrophages and DCs. As discussed in detail previ-
ously (6), this lack of correlation between markers is
supported by both ﬂuorescence-activated cell sorter pro-
ﬁling and immunohistochemistry, where the number of
subpopulations that can be deﬁned is a function of the
number of markers examined.
With respect to the macrophage-DC distinction, meta-
analysis of large microarray data sets from mouse and
human (72, 73) produced the same conclusion as anal-
ysis of the ImmGen data; cells annotated as DCs clearly
segregated into two groups. As one might have predicted
based on the original deﬁnition of the DC, the expres-
sion cluster that divided all macrophage/DC-related net-
works into two clear classes was the cluster containing
lysosomal/endocytosis genes described above. The clas-
sical DCs isolated as deﬁned by Steinman had very low
expression of all of the genes in this cluster, and lower
expression of the putative regulators (PU.1, C/EBP, and
MITF family), whereas there was a separate class of cells
that included monocyte- and bone marrow-derived cells
described as “DCs” and many MHC-II-positive myeloid
cells from tissues, which were clearly capable of being
active phagocytes based on their expression of the large
endocytic cluster (67, 72, 81).
The only transcriptional signature associated with
APC activity in both macrophages and “DCs” is a very
small one, including MHC-II, CD74, and the regulator
CIITA. Several recent reviews (82, 86, 87) have con-
sidered the transcriptional control in the development
of the classical DC, and the BioGPS and ImmGen data
conﬁrm the separation of these cells from macrophages.
The data also conﬁrm some of the lineage-restricted
transcription factors in mice that distinguish the classi-
cal, FLT3-dependent DC from the macrophage (86). The
transcription factors that most clearly deﬁne classical
DCs, such as BATF3 and ZBTB46, are transcriptional
repressors. One of the functions of these transcription
factors could be to block macrophage differentiation
and expression of endocytic function (88).
The ImmGen data were also used to deﬁne a number
of surface markers that positively identify “macro-
phages” as distinct from “DCs,” including the Fc recep-
tor CD64 and the signaling molecule MERTK (83).
These two markers did not correlate with each other
in our reanalysis of the ImmGen data. CD64 is a direct
target of CSF-1 signaling in mice and has been consid-
ered a marker, alongside CD163, of M2 polarization
(89). CD64 is absent from elicited peritoneal macro-
phages, whereas MERTK is very highly expressed and
further induced by lipopolysaccharide (LPS) (http://
biogps.org). Therefore, like CD11c discussed above,
their expression is state speciﬁc, and they cannot be
considered as markers for a deﬁnitive “macrophage”
or “DC.” The shortcomings of CD64 as a marker are
illustrated by a study of dermal myeloid cells. CD64 was
used to distinguish CD11b+ macrophages from CD11b+
DCs in the dermis, leading to the conclusion that only
∼10% of the CD11b+ myeloid cells in the dermis are
macrophages (90, 91). The CD11b+ “DCs” were mono-
cyte derived and expressed most other macrophage
“markers” (e.g., F4/80, CD68, and lysozyme) (90, 91).
Alongside Langerhans cells of the epidermis, the vast
majority of dermal myeloid cells expressed a Csf1r-
EGFP (enhanced green ﬂuorescent protein) transgene
and were completely ablated by treatment of mice with
anti-CSF-1R antibody (59). A recent proposal for a uni-
ﬁed nomenclature that separates macrophages and DCs
based on ontogeny and growth factor dependence would
clearly separate the CD11b+ DCs in skin, which are
CSF-1 dependent, from classical DCs, which depend on
FLT3 ligand (92). This distinction would also separate
the putative classical DC subclasses in mouse, cDC1 and
cDC2, which differ in expression of the chemokine re-
ceptor XCR1 (GPR5) and CD8 (86). Within the BioGPS
data, the CD8+ DCs expressGpr5 at high levels and lack
Csf1r. Plasmacytoid DCs also lack Csf1r mRNA. Con-
versely, the CD8– DCs lack GPR5 and expressed both
Csf1r and Flt3, and detectable EMR1 (F4/80). It is not
clear that the markers are expressed on the same
cells within this population. What is clear is that the
deﬁnition of cDC2s as distinct from macrophages is
rather more contentious (86).
The separation of cell populations based on cell
surface markers is clearly a mainstream technology in
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immunology. Objections to the use of markers are not
solely semantic. The core problem lies with the concept
of a marker. A marker is only useful if it actually predicts
function. Markers expressed by T lymphocytes such as
CD3, CD4, and CD8 are informative, and predictive,
because they are required for the function of the cells in
which they are expressed, and they are, in fact, very well
correlated with expression of genes required for lineage-
speciﬁc function. The endosome/lysosome gene cluster
discussed above is also clearly linked to function. Any
one of the genes present within that cluster has a pre-
dictive value as a marker; a cell that expresses it is likely
to be phagocytic. On the other hand, CD11b and CD11c
encode complement receptors that have no function
in antigen presentation. They are clearly likely to be
required for complement receptor function, but there
is no reason a priori to suspect that they will be highly
expressed in APCs. The obvious counterargument is
that markers are useful; they can be used to purify pop-
ulations of cells that are enriched for a particular func-
tion of interest. However, the expression data tell us that
such populations are intrinsically heterogeneous.
GENETIC VARIATION AND
MACROPHAGE BIOLOGY
Like the studies of macrophage ontogeny above, the
ImmGen and BioGPS data sets and much of the literature
on antigen presentation and DC/macrophage divergence
derive from the C57BL/6 mouse. In mice, many tissue
macrophages, and cells grown in CSF-1, lack MHC-II,
whereas inmost other species, including humans and pigs,
monocytes and monocyte-derived macrophages (MDMs)
are strongly MHC-II positive. Furthermore, the C57BL/6
mouse has only one MHC-II locus since H2-Ea is absent.
This locus is inducible by LPS in macrophages from
BALB/c mice (93). C57BL/6 macrophages do not express
cathepsin E, which is needed for antigen processing (93).
A gene promoter polymorphism in the arginine trans-
porter, Slc7a2, means that C57BL/6 mice have very dif-
ferent rates of arginine metabolism than other strains
(94). At least 65 genes distinguish the transcriptome of
C57BL/6 macrophages absolutely from BALB/c macro-
phages (93), including the C1q components proposed as
unique markers for microglia (95), which were much
more highly expressed and inducible in C57BL/6 than
in BALB/c mouse macrophages (93). Strain-speciﬁc vari-
ation in gene expression is also reﬂected in allele-speciﬁc
methylation patterns in macrophages from an F1 cross
between these strains (96), and there is similar diversity
between other mouse strains (97, 98). This means that a
view of the MPS or the macrophage transcriptome based
on the biology of the C57BL/6 mouse may not be gen-
eralizable to all mice, let alone to other species.
TRANSCRIPTIONAL REGULATION AND
MACROPHAGE DIFFERENTIATION
Whether or not tissue macrophages derive from de-
ﬁnitive progenitors in the marrow, and must transit
through a blood monocyte precursor, it is possible to
isolate committed progenitor cells from bone marrow
that express receptors for hematopoietic growth factors,
and to use those growth factors to generate relatively
pure populations of macrophages (in CSF-1), classical
DCs (in FLT3L), or macrophages with APC activity
(in granulocyte-macrophage CSF [GM-CSF]; otherwise
called bone marrow-derived DCs). Some of the under-
lying transcriptional regulation of lineage commitment
in mice has been inferred from large-scale transcriptomic
proﬁling of puriﬁed progenitor cells (99–102). Similarly,
there have been detailed transcriptomic studies of the
differentiation of human blood monocytes to mature
macrophages, or DCs, in the presence of CSF-1 or GM-
CSF (103, 104). The process of macrophage differenti-
ation can also be modeled to some extent using myeloid
leukemia cell lines. The FANTOM4 (Functional Anno-
tation of the Mammalian Genome) consortium used
the THP-1 human monocytic leukemia line to study the
cascade of transcriptional events associated with mac-
rophage differentiation (105). Genome-scale 5′ rapid
ampliﬁcation of cDNA ends (5′ RACE; also known as
cap analysis of gene expression [CAGE]) was used in
parallel with microarrays to identify changes in pro-
moter activity with time and to infer the transcription
factors involved. One of the most interesting ﬁndings
was the rapid downregulation of a large cohort of tran-
scriptional regulators, exempliﬁed by c-MYB, and the
ﬁnding that small interfering RNA-mediated down-
modulation of those factors was sufﬁcient to drive the
differentiation process (105).
The largest data sets available for human macrophage
differentiation have come from the FANTOM5 consor-
tium, which also utilized CAGE to identify the sets of
promoters and enhancers utilized by hundreds of dif-
ferent cells and tissues (106, 107). These data sets include
multiple samples of different human myeloid lineages,
including multipotent progenitors (CD34+ stem cells),
common myeloid progenitors (CMPs), and granulocyte-
macrophage progenitors (GMPs), three monocyte sub-
sets deﬁned by CD14 and CD16 expression, MDMs
(grown in CSF-1), monocyte-derived “DCs” (MDCs;
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grown in GM-CSF plus IL-4), Langerhans cells (LC) and
migratory DCs from skin lymphatics. Although there are
subtle differences in experimental systems and puriﬁca-
tion protocols, the data complement and parallel two
large data sets generated by the Blueprint consortium,
one of which proﬁled transcriptional regulation in iso-
lated human progenitor cells (99), and another which
detailed the human monocyte response to CSF-1 and
tolerization with LPS (108).
The expression proﬁles of myeloid lineage cells have
been analyzed separately from the complete FANTOM5
data set (109) and data access provided on a separate
portal at http://www.myeloidome.roslin.ed.ac.uk. This
portal enables visualization of the transcription start
sites and expression proﬁles in this set of myeloid cell
types of any gene of interest, using the genome browser.
It also summarizes expression proﬁles of long noncoding
RNAs and microRNAs and cell type enhancers that
correlate in their expression with promoters in the same
genomic region.
Figure 1 shows the expression levels of key growth
factor receptors in a macrophage-DC differentiation
series extracted from the human FANTOM5 gene ex-
pression data. The combined total expression of these
ﬁve growth factors was remarkably similar across all
cell types, but the proportion of total expression con-
tributed by each gene varied considerably. Consistent
with the identity of the samples, KIT (receptor for stem
cell factor), FLT3, CSF2RB (GM-CSFR), and CSF3R
(G-CSFR) are expressed in progenitors, the CD34+ mul-
tipotent stem cells (MSCs), the CMPs, and the GMPs.
Csf1r is ﬁrst expressed in the GMPs. Outside of the
progenitor population, Csf1r and FLT3 show opposite
expression patterns; the classical DCs express FLT3
and all other populations, including monocyte-derived
“DCs” and Langerhans cells of the skin (sometimes
regarded as DCs), express Csf1r. As expected, given
the clinical use of G-CSF for stem cell mobilization,
CSF3R is expressed in the CD34+ progenitors, but in-
terestingly, its expression is retained in CD14+ mono-
FIGURE 1 Expression of selected genes encoding myeloid-restricted growth factor
receptors. Stacked bars show expression of each gene in the cell type (normalized
tags per million) derived from FANTOM5 CAGE data for human cells (107). Cell types are
presented in the order of maturation: CD34+ MSCs; CMPs; GMPs; migratory DCs; CD14++
monocytes (CD14++ Mo); CD14+CD16+ monocytes (CD14+, CD16+ Mo); CD16+ mono-
cytes (CD16+ Mo); MDMs (cultured in CSF-1); monocytes cultured in GM-CSF (MDCs); and
migratory DCs from skin lymphatics (LC).
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cytes and downregulated with maturation in response
to CSF-1, varying inversely with Csf1r mRNA. The ex-
pression of CSF3R in monocytes and their progenitors
may be related to the ﬁnding that G-CSF treatment of
humans mobilizes a population of monocytes that retain
expression of CD34 (110).
As we concluded from a meta-analysis of published
human microarray data (73), the transcriptional pro-
ﬁles of monocyte-derived populations grown in different
growth factors clustered together, ﬁrst and foremost
because of their shared expression of phagocytic genes
and some endocytic receptors (109). Many transcripts
were more highly expressed in monocyte-derived mac-
rophages grown in CSF-1 (ACP5, CD163, C1Q, tet-
raspanins, IGF1, VEGFB, scavenger receptors, and
CHI3L1) or the monocytes grown in GM-CSF (CD1A,
-B, -C, and -E; DCSTAMP; CLEC4A; CLEC10A;
CLEC4G; and TNFRSF11A, also known as RANK).
As in other data sets discussed above, the MHC-II
genes were separately clustered because they are also
expressed by monocytes and their committed pro-
genitors. As expected, the monocyte-derived “DC” cells,
grown in GM-CSF, maintained higher levels of the
MHC-II cluster, whereas these genes were somewhat
repressed in the monocytes grown in CSF-1.
The three human monocyte populations in the
FANTOM5 data set were also subjected to detailed
chromatin analysis, providing global maps of H3K4me1
(promoter) and H3K27ac (enhancer) locations that
largely conﬁrmed the CAGE data (111). The CAGE-
based methodology also permitted identiﬁcation of
regulated enhancer activity, enabling, for example, the
identiﬁcation of active enhancers responsible for the
differential expression of CD14 in the monocyte sub-
populations. Over all, the FANTOM5 data supported
the view that the monocytes are a CSF-1-dependent
differentiation series, with the intermediate monocytes
showing intermediate expression of the vast majority of
the hundreds of genes that showed differential expres-
sion between the two extremes of monocyte phenotype.
This pattern includes Csf1r itself, which is 3-fold ele-
vated in CD16++ monocytes. The one exception, con-
sistent with ﬁndings of others (reviewed in references
10–12), is ∼2-fold elevation of a subset of MHC-II
(HLA-DP, HLA-DQ, and HLA-DR) transcripts in the
intermediate cells relative to CD14++ and CD16++ ex-
tremes, despite a progressive decline in expression of the
regulator CIITA. If monocytes are a differentiation se-
ries, the selective increase in the intermediate population
reported in many clinical settings probably represents a
change in transit time between the states.
Aside from CD14 and CD16, two other markers
have been proposed to provide functional delineation
of subsets of human monocytes: TIE2 and SLAN (10,
12). The former encodes a tyrosine kinase receptor for
angiopoietin-2, but it was not detected in any of the
monocyte preparations in FANTOM5, where it was
highly expressed as expected in endothelial cells. SLAN
is an antigen formed by a novel O-linked 6-sulfo-LacNac
modiﬁcation of P-selectin glycoprotein ligand (PSGL1).
PSGL1 is itself around 2 times more highly expressed in
CD16++ monocytes than CD14++ monocytes. However,
the enzyme most likely to be required for the modiﬁca-
tion, carbohydrate sulfotransferase 2, was undetectable
in CD14++ monocytes, induced in intermediate cells,
and highly expressed in CD16++ cells. One other marker,
CD43, has been used in other species as a subset marker
(10, 12), and the FANTOM5 data demonstrate that it is
likely to provide a similar discrimination of the CD16++
subset in humans.
The analysis of monocyte subsets by FANTOM5
identiﬁed the coregulation of genes required for glyco-
lytic metabolism and the metabolic burst in the classical
monocytes (111). Conversely, the CD16++ monocytes
were apparently more committed to oxidative metabo-
lism and mitochondrial energy generation. It may be
that the more mature, long-lived monocytes adapt with
time to the aerobic environment of the bloodstream,
where the “inﬂammatory” monocytes are adapted to
enter the relatively low-oxygen environments of tis-
sues and inﬂammatory sites. Among the genes strongly
downregulated in the CD16++ monocytes is the hypoxia-
inducible transcription factor HIF1A and the glucose
transporter GLUT3 (SLC2A3).
About two-thirds of the annotated transcription
factors in the genome can be detected in some state of
differentiation or activation of the macrophage line-
age. Most do not vary greatly in their expression across
myeloid lineages. About 100 transcriptional regulators
showed signiﬁcant variation with differentiation in the
populations shown in Fig. 1. An analysis of the mono-
cyte cell types based on expression of 108 transcription
factor and growth factor receptor genes was performed
using BioLayout Express3D (70). Eleven coexpression
clusters containing three or more genes were identiﬁed.
The patterns of these 11 clusters are shown in Fig. 2, and
their proﬁles are summarized in Table 1. The largest
cluster consisted of the set of transcription factor genes
that was expressed in progenitors and downregulated
with differentiation. All of these genes were highly ex-
pressed in C57BL/6 mouse progenitor cells and down-
regulated with differentiation (http://biogps.org). Many
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of them were also expressed constitutively by THP1 cells
and downregulated in response to phorbol myristate
acetate-induced differentiation (105).
Among these coregulated transcription factors, clus-
ters 3 and 6 were expressed most highly in the classical
monocytes and declined with maturation to the CD16+
subset, and still further in response to differentiation
in vitro. Conversely, cluster 4 included transcription fac-
tors such as CEBPB, MAFB, and TFEB that increased
with monocyte differentiation and still further in re-
sponse to CSF-1 in vitro. The results are broadly con-
sistent with a recent review of monocyte differentiation
FIGURE 2 Network layout of 108 growth factor receptor and transcription factor genes
in myeloid lineages. Nodes represent genes and edges correlation between expression
patterns of genes at a Pearson correlation coeﬃcient of 0.74 or greater. Nodes of the
same color form a cluster. Histograms show the average expression pattern of genes
within the cluster. x axis, cell type. Each column represents one cell type, presented in
the order of maturation: CD34+ mesenchymal stem cells; CMPs; GMPs; migratory DCs;
CD14++ monocytes; CD14+CD16+ monocytes; CD16+ monocytes; MDMs (cultured in
CSF-1); monocytes cultured in GM-CSF; andmigratory DCs from skin lymphatics. Column
colors are the same as the nodes in the cluster. y axis, average expression of genes in the
cluster (normalized tags per million) derived from FANTOM5 CAGE data for human cells
(107).
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by Huber et al. (112) but greatly extend the transcrip-
tional network. In every case, the CD14+CD16+ cells
have intermediate expression, again reinforcing the view
that they are a differentiation intermediate between the
CD14++CD16– and CD14–CD16++ subsets. A number
of genes of interest have idiosyncratic expression pat-
terns and are not included in clusters (not shown). For
example, BATF3, the mouse DC regulator mentioned
earlier, was expressed in human monocytes and in-
creased markedly with maturation to the CD16++ sub-
set. It was maintained in monocytes grown in GM-CSF
but ablated in those grown in CSF-1. In mice, the gen-
eration of the Ly6C–, or nonclassical, monocyte subset
depends on the CSF-1-responsive early response gene
Nr4a1 (Nur77) (113). TheNr4a1 gene was a member of
cluster 3, and it is likely that NR4A1 protein also per-
forms some function in maturation in humanmonocytes.
CSF1R, THE ARCHETYPAL
MACROPHAGE-SPECIFIC GENE
The CSF-1 receptor (Csf1r) locus has been studied in
great detail to provide an understanding of the pro-
cesses of macrophage differentiation. Expression of
Csf1r mRNA is one of the earliest markers of macro-
phage lineage commitment from multipotent progeni-
tors in mouse bone marrow, as well as the appearance of
macrophages in the yolk sac (32, 114). In the mouse,
CSF-1 was shown to direct myeloid lineage fate in single
multipotent HSCs by activating the expression of tran-
scription factor PU.1 (115). This ﬁnding appears in-
compatible with human and mouse transcriptomic data
(both in FANTOM5 and in BioGPS), which indicate that
Spi1 (encoding PU.1) is already highly expressed in
CD34+ MSCs, whereas Csf1r is ﬁrst detectable in GMPs
(see Fig. 1). Further, the TATA-less, macrophage-speciﬁc
promoter of the Csf1r locus in both species contains
multiple PU.1/ETS binding sites that are bound by PU.1
and required for maximal activity (116, 117), and PU.1
is required forCsf1r expression in progenitor cells (116).
Hence, a model that places PU.1 downstream of CSF-1R
signaling does not ﬁt the available expression data.
Tagoh et al. (114) puriﬁed mouse c-KIT-positive pro-
genitors and conﬁrmed that (i) they express c-MYB and
PU.1 and (ii) they lack surface CSF-1R as well as Csf1r
mRNA. These cells require a cocktail of IL-1, IL-3, and
CSF-1 to drive macrophage differentiation. The critical
event that permits the expression of Csf1r and lineage
commitment is more likely loss of c-MYB rather than
induction of PU.1 (118). Detailed studies of the chro-
matin structure of the mouse Csf1r locus during differ-
entiation of progenitors (114) revealed the occupation of
both purine-rich motifs and C/EBP binding sites in the
Csf1r promoter in the immature precursors, consistent
with expression of both PU.1 and CEBP family members
in these cells. These ﬁndings indicated that regulatory
elements elsewhere in the locus drive transcriptional
activation of Csf1r transcription during differentiation.
Multiple analyses of transcription factor binding site
occupancy and epigenetic proﬁles in mouse and human
TABLE 1 Coexpression of transcription factor genes in cells of myeloid lineagesa
Cluster Description Transcription factor genes
1 High in precursors (FLT3+, KIT+) BACH2, DACH1, E2F1, E2F3, EGR1, ERG, ELF2, FOXP1, GFI1, GFIB,
HOXA9, JUND, LMO2, MYB, MYC, MYCN, NFE2, PRDM8, RFX8,
RUNX1, SOX12, TAL, TCF3, TCF4
2 High in precursors and monocytes; down in MDMs, MDCs,
and G-CSFR+
ELF1(A), ETS2, FLI1, FRA2, KLF7, PER1, PER2, SMAD3
3 Declines with maturation from MSCs through monocyte
subsets to MDMs/MDCs; retained in LCs
ATF3, FOSB, FRA1, IRF6, JUN, MAFF, NFATC1, NR4A1, NR4A2
4 Highest in monocytes and MDMs, increased in
CD16+ monocytes
CEBPB, IRF7, KLF2, LMO2 (C), MAFB, NR1D1, POU2F2, TCF7L2, TFEB
5 Highest in SCs, migratory DCs, and LCs; declines with
monocyte maturation
ARNT, BHLHE40, ETV3, ID2, NR4A3, PRDM1, REL, RELB, ZBTB46
6 Highest in CD14+ monocytes, declines in CD16+,
and suppressed in MDMs/MDCs
CEBPD, FOS, HIF1A, JDP2, KLF4, MEF2C
7 Induced in MDMs, low in all others BHLHE41, EGR2, ETV5, MAF, MITF, NR1H3 (LXRA), PPARD
8 Induced in both MDMs and MDCs CREG1, PPARG, SNAI3, TFEC
9 High in MDCs, also increased in MDCs and LCs ARNTL2, CIITA, IRF4, SPIB
10 High in SCs, down in CMPs ETS1, SMAD7, SOX4
11 High in MDCs (GM-CSFR++) CEBPA, FOXQ1
aCluster numbers are derived from the BioLayout Express3D analysis shown in Fig. 2. Transcription factors are those with high expression in the cluster. MDM, monocyte-
derived macrophage (cultured in CSF-1); MDC, monocyte cultured in GM-CSF plus IL-4; LC, Langerhans cell. Migratory DCs are cells isolated from skin lymphatics.
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provide a consistent view of potential regulatory ele-
ments in the Csf1r locus (104, 111, 119, 120), summa-
rized in Fig. 3.
The purine-rich promoter architecture of Csf1r is
shared by other myeloid-speciﬁc promoters, and basal
activity requires cooperation between PU.1 and other
ETS family transcription factors (121) as well as binding
of Ewing sarcoma protein or the related FUS/TLS to
the transcription start site (TSS) (122). Multiple ETS
family members expressed in precursors and monocytes
(ERG, ELF2, ELF1, ETS2, FLI1, ETV3, and ETV5;
Table 1) are likely to fulﬁl the role of cooperating with
PU.1 to activate purine-rich promoters. Conserved
candidate enhancer sites upstream of the major macro-
phage Csf1r TSS, and within several introns, are also
evident in chromatin analysis (104, 111, 119, 120), and
the enhancer activity was conﬁrmed based on bidirec-
tional promoter activity in data from both human and
mouse macrophages from the FANTOM5 consortium
(106, 107). All mammalian Csf1r genes contain a con-
FIGURE 3 Chromatin architecture of the mouse and human Csf1r loci. Genome browser
tracks of indicated histone modiﬁcations and transcription factors associated with en-
hancer elements are shown. The ﬁlled green box indicates the macrophage promoter.
Boxes in blue identify intergenic and intragenic enhancer candidates. FIRE is represented
by a ﬁlled blue box. Chip-Seq data sets that formed the basis of this ﬁgure for human
macrophages are from derived from references 104 and 159. The mouse PU.1 track is
derived from reference 136, and other mouse tracks from ENCODE.
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served intronic enhancer referred as the Fms intronic
regulatory element (FIRE) (123, 124). Tagoh et al. (114)
demonstrated by in vivo footprinting that activation of
mouse Csf1r transcription in c-KIT-positive precursors
involves sequential occupation of multiple sites in the
FIRE region. FIRE provides a remarkable cluster of
highly conserved binding sites for many of the regulated
transcription factors shown in Table 1, notably GC-rich
elements likely bound by EGR1/EGR2 and KLF family
members (104, 116, 125).
Csf1r reporter mice have been especially useful for
studies of both CSF-1 and anti-CSF-1R treatments (55,
59, 126). A Csf1r-EGFP reporter containing the Csf1r
promoter plus FIRE was detectable in all myeloid cells
throughout the body, generating the MacGreen mouse
(123) as well as constitutive and tamoxifen-inducible
Csf1r-Cre transgenes used in lineage trace studies (44,
127). A 150-bp distal promoter element, containing a
conserved AP1 site, is required for expression in mature
macrophages and osteoclasts (128). The MacBlue trans-
genic line (Csf1r-ECFP [enhanced cyan ﬂuorescent pro-
tein]) was generated using a promoter with this element
deleted (129, 130). The reporter protein was expressed
on macrophages as they appeared in the yolk sac and
provided a striking picture of their abundance during
embryonic development (30). Unexpectedly, the expres-
sion disappeared from the majority of tissue macro-
phages postnatally, whereas expression was retained in
bloodmonocytes and their progenitors, and in the IL-34-
dependent populations, the microglia and Langerhans
cells in the skin (30). Even in the gut, where the mac-
rophage population clearly derives from continuous re-
newal from monocytes (46), the Csf1r-ECFP transgene
was extinguished in the majority of resident macro-
phages. The transgene therefore permits live imaging of
monocyte trafﬁcking (131).
Expression of the reporter genes based on the Csf1r
locus requires the activity of FIRE (123), and the activity
of FIRE is functionally conserved across mammalian
species (132). FIRE is conserved also in the Csf1r locus
of birds, and Csf1r reporter transgenic chickens have
been produced in which all of the macrophages are la-
beled from the earliest yolk sac-derived cells (133). The
chick provides an alternative model to study the origin
of macrophages, and is the model in which the yolk sac-
derived macrophages were ﬁrst described (35, 134).
Using transgenic reporters, we found that macrophages
derived from the yolk sac are capable of extensive pro-
liferation in response to CSF-1 in vitro, and in response
to CSF-1 administration into the embryo. When trans-
planted to a nontransgenic recipient, they give rise to
macrophages all over the body. However, these cells
are not retained anywhere after hatching. By contrast,
transplantation of cells from hatchling bone marrow
into embryos prior to the onset of deﬁnitive hemato-
poiesis produced extensive macrophage chimerism in
the embryo that was retained in mature adult birds, and
which included regeneration of macrophage progenitors
of donor origin in the marrow (36). We suggest that the
trophic environment of the early embryo can only sup-
port the committed macrophage progenitors, perhaps
similar to those of mouse (37). In keeping with the ear-
liest ﬁndings using chick-quail yolk sac chimeras (134),
these ﬁndings suggest that the contribution of the yolk
sac to tissue macrophage populations is transient, and
yolk sac-derived cells are replaced entirely by the prog-
eny of deﬁnitive hematopoiesis.
TISSUE-SPECIFIC ADAPTATION AND
ACTIVATION OF MACROPHAGES
Regardless of the embryonic origin, each population of
tissue-resident macrophages adapts speciﬁcally to the
environment in which it ﬁnds itself. Sample-to-sample
comparison of the extensive ImmGen data set for the
mouse demonstrated that each tissue macrophage pop-
ulation formed a distinct cluster (81). One recent study
focused on the differentiation of microglia, the macro-
phages of the brain, and identiﬁed a marker set that
distinguished these from blood monocytes and from tis-
sue macrophages isolated from other locations (95). The
BioGPS data, the FANTOM5 data, and the ImmGen
data all include strongly validated microglial data sets.
The former two conﬁrm known microglial-enriched
genes including Aif1 (Iba1) and the scavenger receptors
Fcrls and Marco but do not support others such as
C1q and Csf1r, which are also highly expressed in other
macrophage populations. A more extensive comparison
combined expression proﬁling of isolated mouse tis-
sue macrophage populations with extensive analysis of
chromatin architecture (135, 136). Several of the genes
that marked particular macrophage populations were
transcription factors, notably Sall1 andMef2c in microg-
lia, Gata6 in peritoneal macrophages, Lxra in Kupffer
cells, Spic in spleen, and Runx3 in the gut (135). The
expression of Gata6 in mouse peritoneal macrophages
appears to be required for their self-renewal and ho-
meostasis; two groups separately reported on the select
impact of myeloid-speciﬁc deletions of the gene in the
resident peritoneal population (137, 138). The tissue-
speciﬁcmacrophage phenotypes correlatedwith the pres-
ence of H3K4Me1/2 enhancer proﬁles in their genomic
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vicinity. The role of environment in the acquisition of
tissue-speciﬁc phenotypes was examined in bone mar-
row chimeras. The outcomes indicated not only that
the tissue determines the phenotype but, inter alia, that
monocytes derived from bone marrow progenitors can,
and do, give rise to tissue-resident macrophages if the
niche is available.
There is considerably less data available on tissue-
speciﬁc macrophage development from other species.
However, the number of macrophages in most organs is
sufﬁciently high that we can extract a macrophage sig-
nature without isolating the cells. Within the pig gene
expression atlas, we proﬁled lung alveolar macrophages,
blood monocytes, and bone marrow-derived macro-
phages alongside many different tissues (66). Compara-
tive analysis revealed that alveolar macrophages express
exceptionally high levels of a wide diversity of C-type
lectin receptors (SIGLEC and CLEC family members)
and Toll-like receptors (TLRs), presumably to deal with
inhaled particles. This pattern is also evident in the many
proﬁles of human alveolar macrophages that can be
accessed through NCBI GEO. By contrast, in the wall of
the gut we could detect a clear signature of the abundant
lamina propria macrophage population, but the C-type
lectins and TLRs were absent.
The apparent plasticity of tissue macrophages re-
ﬂects, in part, their responsiveness to numerous different
stimuli, some of which are tissue speciﬁc and others
shared by locations or induced in response to environ-
mental challenges. The generic term “activation” was
originally applied to the ability of recruited macro-
phages to acquire microbicidal and tumoricidal activity
in response to products of activated T cells. A number
of groups have advocated subclassiﬁcation of the acti-
vation states seen in recruited macrophages, broadly
into M1 and M2 or classically activated and alterna-
tively activated (5, 139–141). The M1 and M2 nomen-
clature links the state of activation of the macrophages
to the activation of Th1 and Th2 lymphocytes, which
in turn links them to the actions of gamma interferon
(IFN-γ; originally known as macrophage-activating fac-
tor) (142) and IL-4. Interestingly, although it is not com-
monly regarded as a macrophage growth factor, IL-4
can promote macrophage proliferation in mice in vivo
(57, 143).
The proposed M1/M2 dichotomy is not supported
by genome-scale data (73). If there were coordinatedM1
or M2 “regulons,” we would expect to see correlated
expression of the classical marker genes for the putative
M1 and M2 phenotypes across different cellular states,
and this was not observed. The utility of the M1/M2
concept across species is also not clear. The gene ex-
pression proﬁles of “classically activated” mouse, pig,
and human macrophages are very different (144), with
the pig being rather more human-like (145). Similarly,
the IL-4-inducible alternatively activated proﬁles, and
putative M2 markers, are poorly conserved between
mouse and human. Transglutaminase 2 was proposed
as the only well-conserved marker (146). Mosser and
Edwards (147) suggested that macrophage activation
may better be described as a spectrum, analogous to
a color wheel. Xue et al. (148) conﬁrmed the spec-
trum model with an extensive comparison of human
monocyte-derived macrophages grown in CSF-1 or
GM-CSF and exposed to numerous distinct stimuli in-
cluding IFN-γ, IFN-β, IL-4/IL-13, IL-10, glucocorticoids,
TLR agonists, tumor necrosis factor, and prostaglandin.
While there was a broad dichotomy between IFN-γ (M1)
and IL-4 (M2) directed states, addition of further stimuli
segregated the transcriptional response into many sep-
arate modules, with 49 distinct coexpression clusters
containing 27 to 884 genes per module (148). The sim-
plistic view of macrophage activation that pervades
the literature is based in part on simpliﬁed models in
which individual agonists are studied individually, often
at a single dose, a single time point, and in a single mouse
strain and/or small subset of individuals. The problem
with this approach is illustrated by several ﬁndings. IFN-
γ is normally made by activated T cells alongside GM-
CSF. As the sole stimulus, IFN-γ causes growth arrest,
whereas when GM-CSF is present, it is a mitogen (149).
On the matter of dose and mouse strain, the dose re-
sponse to LPS differs at the single-gene level (some genes
are induced only by higher doses), and profoundly be-
tween mouse strains (93, 98). And ﬁnally, in humans it
has been shown that some 80% of genes in monocytes
exhibit heritable differences in gene expression and there
is a major divergence in the secondary induction of IFN-
β target genes in response to LPS (150).
A secondary issue is the massive heterogeneity of
gene expression in macrophages at the single-cell level.
Single-cell analysis of LPS-inducible genes in macro-
phages demonstrated essentially bimodal variation be-
tween individual cells; genes are either induced or they
are not (151). The authors in this case sought causal
explanations for this variation based on covariance of
transcription factor expression at the single-cell level.
However, an alternative view is that transcriptional ac-
tivation at the individual gene level is intrinsically pro-
babilistic (152). Stochastic variation in gene expression
may occur even at the single-allele level. Indeed, the
LPS receptor, TLR4, is expressed from only one allele in
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individual cells, with an allele-counting mechanism sim-
ilar to that of the X chromosome (153). This ﬁnding
explains the semidominance of the Tlr4 mutation in
C3H/HeJ mice, since in heterozygotes 50% of cells ex-
press the nonfunctional protein. Conversely, when one
allele is deleted, all cells express Tlr4 (from the other
allele). Furthermore, because of the complex feedback
loops in stimulated cells, in which LPS rapidly induces
inhibitors that block signaling and degrade induced
mRNAs and proteins (154, 155), individual cells show
an oscillating response over relatively short time frames,
eventually reaching a new steady state (156).
Against this background of complexity and hetero-
geneity, Murray et al. (157) proposed a set of guidelines
to be used when describing macrophage activation
states. They propose that descriptions of macrophage
activation in disease states accurately describe the sys-
tem, the way populations were isolated, and then utilize
markers to enhance the description. However, even this
rigorous approach is confounded if each macrophage is
unique, deploying the potential arsenal of host defense
weaponry in distinct combinations that change with
time. The plasticity and diversity of individual macro-
phages may be a necessary part of their innate immune
function, enabling the generation of a combinatorial
diversity that cannot readily be overcome by a single
pathogenicity determinant. An alternative to cell-based
models is to describe diseases in terms of interacting
genes. For example, if one examines very large data
sets of cancer expression arrays, it is possible to extract
a set of coexpressed genes that includes many known
phagocyte markers, and inter alia indicates that there
is a common tumor-associated macrophage signature,
regardless of tumor type, that ﬁts neither M1 nor M2
proﬁles (85).
DATABASES, WEBSITES, AND THE FUTURE
The escalating amount of data on mononuclear phago-
cyte biology coming from genome-scale technologies
now taxes the capacity of any individual to access all
of the useful information about the regulation of their
favorite gene. BioGPS is an example of a new era of
more user-friendly portals, as is the Immunological Ge-
nome portal (http://www.immgen.org). We established
the website http://www.macrophages.com as a com-
munity website for sharing access to macrophage-
related genomic and other information (158), including
the massive promoter-related data sets arising from
the FANTOM projects. Macrophages.com also pro-
vides macrophage-related pathway annotation data and
links to the growing InnateDB (http://www.innateDB
.org), which curates molecular interactions among
macrophage-expressed proteins. The website also con-
tains a curated compendium of major reviews on mac-
rophage biology and transcriptional regulation, many
of which provide much more comprehensive coverage
of subtopics than this brief overview. With completed
genomes, we are seeing comparable data sets available for
other species, including domestic pigs, chickens, sheep,
and cattle, that will underpin more-rigorous studies of
the evolution of innate immunity, and also the recogni-
tion that there is very substantial genetic variation within
species that underlies disease susceptibility loci.
In summary, macrophages are a very diverse cell
type, expressing a subset of surface markers and de-
rived from both yolk sac and circulating monocytes.
While useful information has been gained by studies of
mice, primarily the C57BL/6 strain, these are not always
generalizable to humans and other animals, and more-
extensive studies of larger mammals such as pigs and
sheep, as well as studies utilizing the ﬂexibility and un-
precedented developmental analysis of the chicken, will
be needed to clarify the role, ontogeny, and differential
function of the range of myeloid cells.
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